Advanced Therapy Medicinal Products Market - Global Outlook, Trends - 2025

1
(No Transcript)
2

• REPORT DESCRIPTION

Advanced Therapy Medicinal Products Market The
global advanced medicinal therapy products are
segmented into North America, Latin America,
Europe, Asia Pacific, Middle East, and Africa.
North America is expected to hold a dominant
position in the global advanced medicinal therapy
products market, owing to the development in the
field of cell and gene therapy. For instance, the
innovative gene therapy known as CAR-T or
chimeric antigen receptor T-cell therapy
harnesses the bodys own immune cells to
recognize and attack malignant cells. The T-cells
are harvested and modified with a new gene. The
new gene contains a protein that directs the
T-cells to target and kill leukemia cells that
have a specific antigen on the surface. Moreover,
Food and Drug Administration (FDA) approved first
gene therapy in the U.S. in 2017, leading a new
approach to the treatment of cancer and other
serious and life-threatening diseases.  Moreover,
Kymriah a cell based gene therapy has also been
approved by FDA in 2017 in the U.S. for the
treatment of patients with a form of acute
lymphoblastic leukemia. Furthermore, Asia Pacific
is expected to be the fastest growing region for
the global advanced therapy medicinal products
market mainly due to rising number of skin burns
cases and cancer diseases. Advanced Therapy
Medicinal Products (ATMPs) are innovative
therapies that comprises cell therapy, gene
therapy, and tissue engineered products. Cell
therapy products include cellular immunotherapies
and autologous and allogeneic cells for certain
therapeutic indications including adult and
embryonic stem cells. Whereas, Human gene therapy
refers to products that introduce genetic
material into individuals DNA to replace faulty
or missing genetic material, thus treating a
disease or abnormal medical condition.
3
REPORT DESCRIPTION
Advanced Therapy Medicinal Products Market
Taxonomy On the basis of products, the global
advanced therapy medicinal products market are
segmented into Somatic Cell Therapy Medicinal
Products Tissue Engineered Medicinal
Products Gene Therapy Medicinal Products On the
basis of diseases, the global advanced therapy
medicinal products market are segmented
into Alzheimers Cystic Fibrosis Muscular
Dystrophies Hemophilia Ask for detailed Sample of
the Research Report https//www.coherentmarketin
sights.com/insight/request-sample/1101
4
REPORT DESCRIPTION

• Advanced Therapy Medicinal Products Market Key
  Players
• Major players involved in the global advanced
  therapy medicinal products market include
• Uniqure
• Pfizer
• Bluebird Bio Inc.
• BioMarin Pharmaceutical
• Novartis AG
• GE Healthcare
• Shire Biotechnology
• Kite Pharma.
• Ask for customization https//www.coherentmarketi
  nsights.com/insight/request-customization/1101

5
(No Transcript)
6
(No Transcript)
7
(No Transcript)
8
THANK YOU
To know more about us, visit our website
www.coherentmarketinsights.com For sales
queries or new topics email us on
sales_at_coherentmarketinsights.com For other
queries contact Mr. Shah (Manager - Business Deve
lopment) Coherent Market Insights sales_at_coherentm
arketinsights.com 1-206-701-6702